Durham drugmaker recaptures pre-Covid momentum for glaucoma treatment
May 06, 2021 at 13:19 PM EDT
The company's year-over-year revenue was up 13 percent for the first quarter.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
